Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Non-cash Items (2017 - 2025)

Historic Non-cash Items for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $3.1 million.

  • Puma Biotechnology's Non-cash Items fell 1916.49% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 1916.49%. This contributed to the annual value of $3.6 million for FY2024, which is 22772.07% up from last year.
  • Per Puma Biotechnology's latest filing, its Non-cash Items stood at $3.1 million for Q3 2025, which was down 1916.49% from $726000.0 recorded in Q2 2025.
  • Puma Biotechnology's Non-cash Items' 5-year high stood at $4.3 million during Q1 2021, with a 5-year trough of $145000.0 in Q3 2023.
  • For the 5-year period, Puma Biotechnology's Non-cash Items averaged around $2.1 million, with its median value being $1.8 million (2021).
  • Its Non-cash Items has fluctuated over the past 5 years, first tumbled by 9595.95% in 2023, then soared by 258550.41% in 2024.
  • Puma Biotechnology's Non-cash Items (Quarter) stood at $1.1 million in 2021, then fell by 3.06% to $1.0 million in 2022, then grew by 5.64% to $1.1 million in 2023, then skyrocketed by 227.72% to $3.6 million in 2024, then decreased by 13.08% to $3.1 million in 2025.
  • Its last three reported values are $3.1 million in Q3 2025, $726000.0 for Q2 2025, and $355000.0 during Q1 2025.